July 02, 2019
Ranging from a pair of U.S. Supreme Court cases touching on important False Claims Act and Freedom of Information Act issues to a first-of-its-kind FCA ruling involving cybersecurity claims, courts have issued a number of important decisions for federal contractors in the first half of 2019.
June 21, 2019
The first half of 2019 saw an extraordinary eruption of important court decisions likely to leave lasting marks on the opioid crisis, the False Claims Act, the Affordable Care Act and Medicare reimbursement. Here, Law360 takes stock of consequential health care and life sciences rulings that lawyers need to know.
June 10, 2019
An Illinois federal judge on Friday stood by her decision denying the U.S. Department of Justice's attempt to end what it claims is a meritless whistleblower suit alleging drugmaker kickbacks, saying prosecutors had done only "minimal" investigation into the claims.
April 30, 2019
An Illinois federal judge erred badly by refusing to end a False Claims Act case alleging drugmaker kickbacks, the U.S. Department of Justice argued, denying that its dismissal request reflects hostility toward a whistleblower company that brought the case.
April 17, 2019
The U.S. Department of Justice's newly launched campaign to shrink its False Claims Act docket has hit surprising turbulence as federal judges scrutinize the DOJ's willingness to look the other way on alleged fraud and its disparagement of a company that specializes in bringing FCA cases.
April 15, 2019
An Illinois federal judge on Monday rejected one of the U.S. Department of Justice's high-profile bids to derail a dozen False Claims Act suits filed by a professional whistleblower, finding that the DOJ barely investigated the allegations of drugmaker kickbacks.
January 23, 2019
A company that specializes in bringing False Claims Act cases has launched a scorched-earth attack on the U.S. Department of Justice for seeking dismissal of nearly a dozen suits it filed, accusing the DOJ of trying to "legalize certain kickbacks" to doctors from drugmakers.
December 18, 2018
In a striking development, the U.S. Department of Justice is seeking to terminate 11 False Claims Act cases involving a new theory that patient assistance services supplied by drugmakers are unlawful kickbacks.